Raymond James Trust N.A. Repligen Corp Transaction History
Raymond James Trust N.A.
- $4.55 Billion
- Q3 2024
A detailed history of Raymond James Trust N.A. transactions in Repligen Corp stock. As of the latest transaction made, Raymond James Trust N.A. holds 2,750 shares of RGEN stock, worth $414,507. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,750
Previous 2,275
20.88%
Holding current value
$414,507
Previous $286,000
43.01%
% of portfolio
0.01%
Previous 0.01%
Shares
16 transactions
Others Institutions Holding RGEN
# of Institutions
481Shares Held
56.3MCall Options Held
251KPut Options Held
458K-
Black Rock Inc. New York, NY7.57MShares$1.14 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD7.14MShares$1.08 Billion0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$769 Million0.01% of portfolio
-
State Street Corp Boston, MA1.69MShares$255 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.54MShares$233 Million1.48% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.36B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....